Aspiriant LLC’s Vanguard Intermediate-Term Treasury ETF VGIT Stock Holding History

Aspiriant LLC’s Portfolio VGIT Stock Details VGIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$521K	Sell	9,204 -1,284	-12%	-$74.6K	0.01%	240
2026 Q2	$619K	Sell	10,488 -2,341	-18%	-$138K	0.02%	215
2026 Q1	$764K	Buy	12,829 +1,677	+15%	+$100K	0.02%	178
2025 Q4	$668K	Sell	11,152 -2,239	-17%	-$135K	0.02%	191
2025 Q3	$804K	Buy	13,391 +6,484	+94%	+$387K	0.02%	165
2025 Q2	$413K	Sell	6,907 -2,149	-24%	-$127K	0.01%	217
2025 Q1	$538K	Buy	9,056 +2,484	+38%	+$145K	0.02%	184
2024 Q4	$381K	Buy	+6,572	New	+$386K	0.01%	213

Other funds holding VGIT

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.66B AUM 9.25% 1-Year Est. Return

Foster Group West Des Moines, Iowa $3.68B AUM 13.84% 1-Year Est. Return

Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return

Bangor Savings Bank Bangor, Maine $1.31B AUM 12.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Hanson & Doremus Investment Management Burlington, Vermont $982M AUM 23.83% 1-Year Est. Return

Aspiriant LLC's VGIT Position: Q3 2026 in Review

Aspiriant LLC reduced its Vanguard Intermediate-Term Treasury ETF (VGIT) stake by 12% in Q3 2026, selling an estimated $74.6K and leaving 9,204 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #240.

Aspiriant LLC first reported a position in VGIT in Q4 2024 and has held it in 8 quarters since. The position peaked at $804K in Q3 2025. 227 funds tracked by Wall St. Rank hold VGIT as of Q3 2026.

Aspiriant LLC held 9,204 shares of Vanguard Intermediate-Term Treasury ETF worth $521K as of Q3 2026.
Aspiriant LLC sold 1,284 Vanguard Intermediate-Term Treasury ETF shares in Q3 2026, an estimated $74.6K.
Vanguard Intermediate-Term Treasury ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #240 holding.
Aspiriant LLC first reported a position in Vanguard Intermediate-Term Treasury ETF in Q4 2024 and has held it in 8 quarters since.
Aspiriant LLC's Vanguard Intermediate-Term Treasury ETF position peaked at $804K in Q3 2025.
227 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Treasury ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.